Cited by 111

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

C to U RNA editing mediated by APOBEC1 requires RNA‐binding protein RBM47

Fossat, Nicolas, Tourle, Karin, Radziewic, Tania, Barratt, Kristen, Liebhold, Doreen, Studdert, Joshua B, Power, Melinda, Jones, Vanessa, Loebel, David A F, Tam, Patrick P L·2014·The EMBO Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embr.201438450

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The observed AC-to-AU mutations are most likely generated by A1 plus cofactor A1CF (or other A1 cofactors, such as RBM47); the UC-to-UU mutations by A3A in the sequence variation detected on the SARS-CoV-2 RNA segments.

    “These results suggest that the observed AC-to-AU mutations are most likely generated by A1 plus cofactor A1CF (or other A1 cofactors, such as RBM4732); the UC-to-UU mutations by A3A in the sequence variation detected on the SARS-CoV-2 RNA segments (Fig. 2C).”
  • RBM47 may also enable A1 to perform AC-to-AU editing of SARS-CoV-2 RNA.

    “Given the closely overlapping RNA target and editing efficiency by another A1-cofactor RBM4728,32,35,50, it’s likely that RBM47 may also enable A1 to perform AC-to-AU editing of SARS-CoV-2 RNA.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 20

  1. Sowden MP, Ballatori N, Jensen KL, Reed LH, Smith HC (2002) The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors. J Cell Sci 115: 1027–1039 · DOI
  2. Chen Z, Eggerman TL, Patterson AP (2007) ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components. Am J Physiol Gastrointest Liver Physiol 292: G53–G65 · DOI
  3. Teng B, Burant CF, Davidson NO (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260: 1816–1819 · DOI · Paper page
  4. Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, Giannoni F, Teng BB, Davidson NO, Scott J (1993) The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 268: 20709–20712 · DOI
  5. Lellek H, Kirsten R, Diehl I, Apostel F, Buck F, Greeve J (2000) Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme‐complex. J Biol Chem 275: 19848–19856 · DOI · Paper page
  6. Mehta A, Kinter MT, Sherman NE, Driscoll DM (2000) Molecular cloning of apobec‐1 complementation factor, a novel RNA‐binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol 20: 1846–1854 · DOI
  7. Henderson JO, Blanc V, Davidson NO (2001) Isolation, characterization and developmental regulation of the human apobec‐1 complementation factor (ACF) gene. Biochim Biophys Acta 1522: 22–30 · DOI
  8. Blanc V, Davidson NO (2010) APOBEC‐1‐mediated RNA editing. Wiley Interdiscip Rev Syst Biol Med 2: 594–602 · DOI
  9. Rosenberg BR, Hamilton CE, Mwangi MM, Dewell S, Papavasiliou FN (2011) Transcriptome‐wide sequencing reveals numerous APOBEC1 mRNA‐editing targets in transcript 3′ UTRs. Nat Struct Mol Biol 18: 230–236 · DOI · Paper page
  10. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M et al (1987) Apolipoprotein B‐48 is the product of a messenger RNA with an organ‐specific in‐frame stop codon. Science 238: 363–366 · DOI
  11. Sniderman A, Couture P, de Graaf J (2010) Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol 6: 335–346 · DOI
  12. Loebel DA, Studdert JB, Power M, Radziewic T, Jones V, Coultas L, Jackson Y, Rao RS, Steiner K, Fossat N et al (2011) Rhou maintains the epithelial architecture and facilitates differentiation of the foregut endoderm. Development 138: 4511–4522 · DOI
  13. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, Turner DJ, Luscombe NM, Ule J (2010) iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol 17: 909–915 · DOI · Paper page
  14. Blanc V, Henderson JO, Kennedy S, Davidson NO (2001) Mutagenesis of apobec‐1 complementation factor reveals distinct domains that modulate RNA binding, protein‐protein interaction with apobec‐1, and complementation of C to U RNA‐editing activity. J Biol Chem 276: 46386–46393 · DOI
  15. Mehta A, Driscoll DM (2002) Identification of domains in apobec‐1 complementation factor required for RNA binding and apolipoprotein‐B mRNA editing. RNA 8: 69–82 · DOI
  16. Hirano K, Young SG, Farese RV Jr, Ng J, Sande E, Warburton C, Powell‐Braxton LM, Davidson NO (1996) Targeted disruption of the mouse apobec‐1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 271: 9887–9890 · DOI
  17. Morrison JR, Paszty C, Stevens ME, Hughes SD, Forte T, Scott J, Rubin EM (1996) Apolipoprotein B RNA editing enzyme‐deficient mice are viable despite alterations in lipoprotein metabolism. Proc Natl Acad Sci USA 93: 7154–7159 · DOI
  18. Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, Chan L (1996) Complete phenotypic characterization of apobec‐1 knockout mice with a wild‐type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec‐1. J Biol Chem 271: 25981–25988 · DOI
  19. Blanc V, Henderson JO, Newberry EP, Kennedy S, Luo J, Davidson NO (2005) Targeted deletion of the murine apobec‐1 complementation factor (acf) gene results in embryonic lethality. Mol Cell Biol 25: 7260–7269 · DOI
  20. Guan R, El‐Rass S, Spillane D, Lam S, Wang Y, Wu J, Chen Z, Wang A, Jia Z, Keating A et al (2013) rbm47, a novel RNA binding protein, regulates zebrafish head development. Dev Dyn 242: 1395–1404 · DOI

Cited by

Sorted by citations

Metadata

Authors
Fossat, N., Tourle, K., Radziewic, T., Barratt, K., Liebhold, D., Studdert, J. B., Power, M., Jones, V., Loebel, D. A. F., & Tam, P. P. L.
Venue
The EMBO Reports
Published
2014-06-10
Volume
15
Issue
8
Pages
903-910
ISSN
  • 1469-221X
  • 1469-3178
Cited by
111
References
1
Language
en
Funders
  • Australian Research Council (DP130100779)
  • University of Sydney Post‐Doctoral Fellowship (1003100)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review